International price regulations in the pharmaceutical sector a vommon model to sharing cost and benefits

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of pharmaceutical finance, economics & policy
1. Verfasser: Capri, Stefano (VerfasserIn)
Weitere Verfasser: Levaggi, Rosella (VerfasserIn)
Format: UnknownFormat
Sprache:eng
Veröffentlicht: 2006
Schlagworte:
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Titel Jahr Verfasser
Drug competition : the Waxman-Hatch act revisited 2006 Virabhak, Suchin
Status of international technology transfer and patent licensing in the medical and pharmaceutical field 2006 Ishee, Jonathan
How much would a medicare prescription drug benefit cost? : offsets in medicare part a cost by increased drug use 2006 Yang, Zhou
International price regulations in the pharmaceutical sector : a vommon model to sharing cost and benefits 2006 Capri, Stefano
Drugs and taxes : lower prescription drug prices through direct tax credits 2006 Acri, Kristina M. L.
Measuring indirect benefits of pharmacy services programm : an economic evaluation using the human capital approach 2005 Lai, L. Leanne
Competition and price discounts for a hospital buyer in the anti-infective pharmaceutical market 2005
Price differences in identical drugs across Central American Countries 2005 Rojas, Mariano
What role may pharmaeconomics play in pharmaceutical pricing and reimbursement in China? 2005 Cai, Qian
Study of the economic burden of depression 2004
Wealth effects of food and drug administration "Fast Track" designation 2004 Alefantis, Timothy G.
Pharmaceutical R&D investment and cash flows : an instrumental variables approach to testing for capital market imperfections 2004 Vernon, John A.
Effect of privatization of the general medical store on the prices of anti-infectives in Malaysis 2004 Babar, Zaheer ud Din
Gender and wage earnings differences among pharmacists 2004 Carvajal, Manuel J.
The relationship between corporate citizenship and financial performance in large publicly traded pharmaceutical, health care, and medical products firms 2004 Longest, Beaufort B.
The pharmaceutical market regulation in Spain : Is drug cost-containment under question? 2004 Costa-Font, Joan
Drug pricing in South Africa : policy and praxis 2003 Gray, Andy
Drug price control in India : an overview 2003 Shah, Mansi B.
Medication expenditure and utilization in Morocco 2003 Senhaji, Batoul
Organization of health care systems and financing of pharmaceuticals in Norway, including cost containments 2003 Bredesen, Geir
Alle Artikel auflisten